Company / Inventory
Zoetis Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$2.4B
FY2025
5-year range
$1.9B / $2.6B
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#11 of 105
Health Care
What the data says
Among 105 Health Care companies, Zoetis is in the top 10% for inventory. Inventory has fluctuated over the past 10 years, ranging from $1.4B in FY2018 to $2.6B in FY2023.
Based on SEC 10-K filings.
$2.4B in FY2025 with a 5-year CAGR of +8.3%. Top quartile in the Health Care sector.
Declined from $2.6B to $2.4B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 105This company $2.4B Sector average $885.3M
▼
+174.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.3%, indicating consistent growth.
- In FY2025, inventory increased 5.4% year-over-year.
- Ranks #11 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4B | +5.4% |
| FY2024 | $2.3B | -10.1% |
| FY2023 | $2.6B | +9.3% |
| FY2022 | $2.3B | +21.9% |
| FY2021 | $1.9B | +18.1% |
| FY2020 | $1.6B | +15.5% |
| FY2019 | $1.4B | +1.4% |
| FY2018 | $1.4B | -2.5% |
| FY2017 | $1.4B | -5.0% |
| FY2016 | $1.5B | +2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026